Compare NKTR & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTR | APPN |
|---|---|---|
| Founded | 1990 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 1996 | 2017 |
| Metric | NKTR | APPN |
|---|---|---|
| Price | $60.25 | $36.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $146.67 | $29.80 |
| AVG Volume (30 Days) | 555.7K | ★ 867.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 101.59 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,711,000.00 | $226,743,000.00 |
| Revenue This Year | N/A | $13.79 |
| Revenue Next Year | N/A | $10.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 86.00 | 28.29 |
| 52 Week Low | $33.40 | $18.63 |
| 52 Week High | $109.00 | $46.06 |
| Indicator | NKTR | APPN |
|---|---|---|
| Relative Strength Index (RSI) | 38.09 | 53.26 |
| Support Level | $65.14 | $35.88 |
| Resistance Level | $76.63 | $44.06 |
| Average True Range (ATR) | 2.76 | 1.81 |
| MACD | -0.69 | -0.34 |
| Stochastic Oscillator | 3.33 | 51.23 |
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
Appian Corp is an enterprise software company whose platform unifies process orchestration, artificial intelligence, and data for automating complex business operations. Its platform combines low-code application development, process automation and process mining, AI agents, and a data fabric that connects information across an organization's existing systems without replicating it. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based, with the remainder coming from services, and much of that subscription revenue comes from its cloud-based platform. Geographically, the company derives maximum revenue from its Domestic operations and also has a presence internationally.